237 related articles for article (PubMed ID: 9409307)
1. Dopamine as a novel antimigration and antiproliferative factor of vascular smooth muscle cells through dopamine D1-like receptors.
Yasunari K; Kohno M; Hasuma T; Horio T; Kano H; Yokokawa K; Minami M; Yoshikawa J
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3164-73. PubMed ID: 9409307
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D1-like receptor stimulation inhibits hypertrophy induced by platelet-derived growth factor in cultured rat renal vascular smooth muscle cells.
Yasunari K; Kohno M; Kano H; Yokokawa K; Minami M; Yoshikawa J
Hypertension; 1997 Jan; 29(1 Pt 2):350-5. PubMed ID: 9039126
[TBL] [Abstract][Full Text] [Related]
3. Anti-atherosclerotic action of vascular D1 receptors.
Yasunari K; Kohno M; Kano H; Hanehira T; Minami M; Yoshikawa J
Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S36-40. PubMed ID: 10386252
[TBL] [Abstract][Full Text] [Related]
4. Vascular dopamine-I receptors and atherosclerosis.
Yasunari K; Kohno M; Kano H; Yokokawa K; Minami M; Yoshikawa J
J Atheroscler Thromb; 1997; 4(2):59-64. PubMed ID: 9638515
[TBL] [Abstract][Full Text] [Related]
5. Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D(1)-like receptors.
Yasunari K; Kohno M; Kano H; Minami M; Yoshikawa J
Circulation; 2000 May; 101(19):2302-8. PubMed ID: 10811599
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells.
Graf K; Xi XP; Yang D; Fleck E; Hsueh WA; Law RE
Hypertension; 1997 Jan; 29(1 Pt 2):334-9. PubMed ID: 9039124
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.
Pukac L; Huangpu J; Karnovsky MJ
Exp Cell Res; 1998 Aug; 242(2):548-60. PubMed ID: 9683541
[TBL] [Abstract][Full Text] [Related]
8. Regulation of rat mesangial cell migration by platelet-derived growth factor, angiotensin II, and adrenomedullin.
Kohno M; Yasunari K; Minami M; Kano H; Maeda K; Mandal AK; Inoki K; Haneda M; Yoshikawa J
J Am Soc Nephrol; 1999 Dec; 10(12):2495-502. PubMed ID: 10589687
[TBL] [Abstract][Full Text] [Related]
9. Cyclic 3',5'-adenosine monophosphate mediates dopamine D1-stimulated growth hormone release from goldfish pituitary cells.
Wong AO; van der Kraak G; Chang JP
Neuroendocrinology; 1994 Oct; 60(4):410-7. PubMed ID: 7529899
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
Kim TJ; Yun YP
Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
[TBL] [Abstract][Full Text] [Related]
11. Dopamine acutely decreases type 3 Na(+)/H(+) exchanger activity in renal OK cells through the activation of protein kinases A and C signalling cascades.
Gomes P; Soares-da-Silva P
Eur J Pharmacol; 2004 Mar; 488(1-3):51-9. PubMed ID: 15044035
[TBL] [Abstract][Full Text] [Related]
12. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation.
D'Angelo G; Lee H; Weiner RI
J Cell Biochem; 1997 Dec; 67(3):353-66. PubMed ID: 9361190
[TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP inhibitors inhibits PDGF-stimulated mitogen-activated protein kinase activity in rat aortic smooth muscle cells via inactivation of c-Raf-1 kinase and induction of MAP kinase phosphatase-1.
Plevin R; Malarkey K; Aidulis D; McLees A; Gould GW
Cell Signal; 1997; 9(3-4):323-8. PubMed ID: 9218135
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor-BB (PDGF-BB) regulation of migration and focal adhesion kinase phosphorylation in rabbit aortic vascular smooth muscle cells: roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinases.
Cospedal R; Abedi H; Zachary I
Cardiovasc Res; 1999 Mar; 41(3):708-21. PubMed ID: 10435043
[TBL] [Abstract][Full Text] [Related]
15. D1 dopamine receptor agonists mediate activation of p38 mitogen-activated protein kinase and c-Jun amino-terminal kinase by a protein kinase A-dependent mechanism in SK-N-MC human neuroblastoma cells.
Zhen X; Uryu K; Wang HY; Friedman E
Mol Pharmacol; 1998 Sep; 54(3):453-8. PubMed ID: 9730903
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach.
Coronas V; Krantic S; Jourdan F; Moyse E
Neuroscience; 1999 Apr; 90(1):69-78. PubMed ID: 10188934
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
Dahmer MK; Senogles SE
J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids.
Sun J; Sui X; Bradbury JA; Zeldin DC; Conte MS; Liao JK
Circ Res; 2002 May; 90(9):1020-7. PubMed ID: 12016269
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor stimulates phospholipase C-gamma 1, extracellular signal-regulated kinase, and arachidonic acid release in rat myometrial cells: contribution to cyclic 3',5'-adenosine monophosphate production and effect on cell proliferation.
Boulven I; Palmier B; Robin P; Vacher M; Harbon S; Leiber D
Biol Reprod; 2001 Aug; 65(2):496-506. PubMed ID: 11466218
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
Deveney AM; Waddington JL
Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
